This study will assess the impact of early initiation (less than one week postpartum) and delayed initiation (4 weeks postpartum) of two types of progestin-only contraceptive pills (POPs) on maternal, breastmilk, and infant outcomes.
This is a placebo-controlled randomized controlled trial enrolling dyads of mothers and their newborn babies. We will explore if the type and timing of initiation of pills is acceptable to the user with minimal side effects, impacts the supply or composition of breastmilk, and/or affects infant growth.
Women will be randomly assigned to 1 of 3 groups and will be blinded to group assignment:
| Condition | Lactation Insufficiency, Lactation, Breast Feeding, contraceptive method, Contraception, birth control method, Birth Control |
|---|---|
| Treatment | Progestin Only Contraceptive Pills |
| Clinical Study Identifier | NCT04965116 |
| Sponsor | University of California, San Diego |
| Last Modified on | 7 July 2022 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.